SLGL Insider Trading
Insider Ownership Percentage: 66.51%
Insider Buying (Last 12 Months): $3,464,525.55
Insider Selling (Last 12 Months): $0.00
Sol-Gel Technologies Share Price & Price History
Current Price: $79.34
Price Change: ▼ Price Decrease of -9.059 (-10.25%)
As of 03/5/2026 12:18 PM ET
Sol-Gel Technologies Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 1/27/2026 | Opaleye Management Inc. | Major Shareholder | Buy | 100 | $57.05 | $5,705.00 | 449,944 |  |
| 1/23/2026 | Opaleye Management Inc. | Major Shareholder | Buy | 1,151 | $55.98 | $64,432.98 | 449,844 | |
| 1/22/2026 | Opaleye Management Inc. | Major Shareholder | Buy | 2,173 | $56.57 | $122,926.61 | 448,693 | |
| 12/31/2025 | Opaleye Management Inc. | Major Shareholder | Buy | 22,497 | $41.99 | $944,649.03 | 443,739 | |
| 12/30/2025 | Opaleye Management Inc. | Major Shareholder | Buy | 35,169 | $41.99 | $1,476,746.31 | 421,242 | |
| 12/29/2025 | Opaleye Management Inc. | Major Shareholder | Buy | 8,638 | $41.85 | $361,500.30 | 386,073 | |
| 12/26/2025 | Opaleye Management Inc. | Major Shareholder | Buy | 1,626 | $41.68 | $67,771.68 | 377,435 | |
| 12/23/2025 | Opaleye Management Inc. | Major Shareholder | Buy | 260 | $41.66 | $10,831.60 | 375,809 | |
| 12/22/2025 | Opaleye Management Inc. | Major Shareholder | Buy | 1,019 | $41.15 | $41,931.85 | 375,549 | |
| 12/17/2025 | Opaleye Management Inc. | Major Shareholder | Buy | 2,735 | $40.37 | $110,411.95 | 374,530 | |
| 12/3/2025 | Opaleye Management Inc. | Major Shareholder | Buy | 2,524 | $37.81 | $95,432.44 | 370,964 | |
| 12/1/2025 | Opaleye Management Inc. | Major Shareholder | Buy | 4,340 | $37.37 | $162,185.80 | 368,440 | |
Sol-Gel Technologies Institutional Trading History
| Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company | Details |
|---|
| 2/18/2026 | Opaleye Management Inc. | 453,739 | $19.12M | 2.5% | +121.5% | 16.286% |  |
| 2/5/2026 | Yelin Lapidot Holdings Management Ltd. | 17,753 | $0.75M | 0.1% | N/A | 0.636% | |
| 9/15/2025 | Migdal Insurance & Financial Holdings Ltd. | 122,755 | $0.91M | 0.0% | -90.0% | 4.400% | |
| 8/14/2025 | Raymond James Financial Inc. | 10,486 | $78K | 0.0% | -90.6% | 0.376% | |
| 8/6/2025 | Yelin Lapidot Holdings Management Ltd. | 17,753 | $0.13M | 0.0% | -92.2% | 0.636% | |
| 7/30/2025 | Phoenix Financial Ltd. | 494,040 | $3.66M | 0.0% | -80.0% | 17.708% | |
| 2/13/2025 | Raymond James Financial Inc. | 108,990 | $0.10M | 0.0% | N/A | 0.391% | |
| 2/6/2025 | Raymond James Financial Inc. | 108,990 | $0.10M | 0.0% | N/A | 0.391% | |
| 8/15/2024 | Armistice Capital LLC | 2,032,000 | $1.81M | 0.0% | -2.2% | 7.294% | |
| 5/16/2024 | Kingdon Capital Management L.L.C. | 481,749 | $0.47M | 0.1% | -28.6% | 1.729% | |
| 3/18/2024 | Kingdon Capital Management L.L.C. | 674,923 | $0.75M | 0.1% | -12.0% | 2.423% | |
| 1/16/2024 | Raymond James Financial Services Advisors Inc. | 43,102 | $48K | 0.0% | -21.8% | 0.186% | |
| 11/15/2023 | Armistice Capital LLC | 2,135,000 | $3.48M | 0.1% | -3.3% | 9.230% | |
| 10/30/2023 | Yelin Lapidot Holdings Management Ltd. | 229,178 | $0.37M | 0.1% | N/A | 0.991% | |
| 7/25/2023 | Raymond James Financial Services Advisors Inc. | 54,180 | $0.16M | 0.0% | -8.2% | 0.234% | |
| 5/15/2023 | Kingdon Capital Management L.L.C. | 770,965 | $2.99M | 0.6% | -7.4% | 3.333% | |
| 4/14/2023 | Raymond James Financial Services Advisors Inc. | 59,006 | $0.23M | 0.0% | +19.6% | 0.255% | |
| 4/14/2023 | Raymond James & Associates | 36,582 | $0.14M | 0.0% | +13.8% | 0.158% | |
| 11/10/2022 | MYDA Advisors LLC | 70,400 | $0.35M | 0.2% | N/A | 0.304% | |
| 10/25/2022 | Raymond James & Associates | 44,803 | $0.23M | 0.0% | -5.8% | 0.194% | |
| 10/25/2022 | Raymond James Financial Services Advisors Inc. | 63,333 | $0.32M | 0.0% | -20.3% | 0.274% | |
| 2/9/2022 | We Are One Seven LLC | 10,040 | $74K | 0.0% | N/A | 0.049% | |
| 2/8/2022 | Raymond James Financial Services Advisors Inc. | 143,205 | $1.06M | 0.0% | +11.0% | 0.702% | |
| 2/7/2022 | Phoenix Holdings Ltd. | 2,574,922 | $19.05M | 0.3% | -1.4% | 12.628% | |
Data available starting January 2016
Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat rare hyperkeratinization disorders, such as Darier, PC, PPK, Olmsted, etc. In addition, the company is also involved in the development of generic topical dermatological drug products. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.
Read More on Sol-Gel Technologies
Today's Range
Now: $79.34
52 Week Range
Now: $79.34
Volume
9,690 shs
Average Volume
24,076 shs
Market Capitalization
$221.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.3
Who are the company insiders with the largest holdings of Sol-Gel Technologies?
Who are the major institutional investors of Sol-Gel Technologies?
Which institutional investors are buying Sol-Gel Technologies stock?
In the last quarter, SLGL stock was bought by institutional investors including:
- Opaleye Management Inc.
- Yelin Lapidot Holdings Management Ltd.
